Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Login

|

2020
December 9
Webinar
LESI IP Valuation Committee “How to Value the Options of a Licensing Strategy?”
LES International
All

Website: https://www.lesi.org/events/upcoming-events/2020/12/09/default-calendar/lesi-ip-valuation-committee-how-to-value-the-options-of-a-licensing-strategy

LESI's IP Valuation Committee invite you to attend a webinar on "How to value the options of a licensing strategy? Exploitation of the Généthon/ Avexis case to identify tools and strategies for future transactions".

From the documents and first business plans drawn up within the framework of the IPV Committee meetings in LES France, we have constructed a strategic analysis of the license agreement concluded between Généthon and Avexis.

The invited speaker is Claus Hirzmann, expert in real option analysis.

Morning Session (for APAC & EU): 10:00am - 11:00am CET
Afternoon Session (for Americas & EU): 4:00pm - 5:00pm CET